Glaxosmithkline Pharmaceuticals Ltd

GLAXO06 Dec 2024
Pharmaceuticals
-30.70 (-1.29%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd
Pharmaceuticals
GLAXO06 Dec 2024
-30.70 (-1.29%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Glaxosmithkline Pharmaceuticals Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
39.18%
Upper Circuit
Lower Circuit
P/E TTM
49.94
P/B Ratio
23.74
Traded Value(Cr)
0.00
EPS TTM
46.98
Book value
Dividend
1.36%

Invest in Glaxosmithkline Pharmaceuticals Ltd at ZERO Brokerage for 30 days

Price Performance

-4.06 %
1 Wk
-10.86 %
1 M
-17.12 %
3 M
39.18 %
1 Y
20.16 %
YTD

Traded Volume Movement

Technical Details

Support 3
2252
Support 2
2293
Support 1
2318
Pivot Point :
2359
Resistance 1
2384
Resistance 2
2425
Resistance 3
2450

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Glaxosmithkline Pharmaceuticals Ltd
₹2,346.40(-30.70/-1.29%)
2,346.40-30.7039,749.4339.1849.9423.74
58.37+0.38447.3143.0650.769.93
Astrazeneca Pharma India Ltd
₹6,632.55(+2.00/0.03%)
6,632.55+2.0016,581.3837.91128.8124.41
Abbott India Ltd
₹29,053.50(+29.75/0.10%)
29,053.50+29.7561,738.6925.9148.0617.53
Amrutanjan Health Care Ltd
₹722.80(-15.20/-2.06%)
722.80-15.202,089.6621.2343.977.02
Bliss GVS Pharma Ltd
₹157.90(-2.90/-1.80%)
157.90-2.901,663.1918.2820.591.62

About Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 39749.43 crores. It has reported a sales of Rs. 1000.05 crores and a net profit of Rs. 248.69 crores for the quarter ended December 2018. The company management includes Renu S Karnad, D Sundaram,A A Nadkarni,P V Bhide,A N Roy,Subesh Williams,Renu S Karnad,Sunita Maheshwari,Manu Anand,Bhushan Akshikar,J. Chandy (Glaxosmithkline Pharmaceuticals Ltd) among others.
Chairman
Renu S Karnad
Registered office
GSK House,Dr Annie Besant Road Worli,Mumbai,Maharashtra,400030
FAX :91-022-24959494
Background
Incorporation Year1924
Face Value₹10
Market Lot1

Latest News

Can Nifty reclaim 24,700, Bank Nifty hold above 53,500 amid consolidation

Both Nifty 50 and Bank Nifty recorded minor profit booking amid volatility on December 6, after rising for five consecutive days. This resulted in small bearish candlestick patterns on the daily charts. The momentum remains strong, but considering the recent healthy rally, the Nifty 50 may see some range-bound trade, with immediate support at 24,500, followed by 24,350 as the key support level.
08 Dec 2024 | 06:12 PM

M-cap of 6 of top 10 most valued firms jumps Rs 2 lakh crore

The market valuation of India's top 10 firms surged Rs 2,03,116.81 crore last week, led by Tata Consultancy Services and HDFC Bank, as the BSE benchmark jumped 1,906.33 points and NSE Nifty climbed 546.7 points. The biggest gainers included Reliance Industries, Infosys, State Bank of India, and ICICI Bank, while Bharti Airtel, LIC, ITC, and Hindustan Unilever were the laggards.
08 Dec 2024 | 12:02 PM

These 3 stocks will likely head north in the coming week- Sudeep Shah

Sensex has found support near its 200-day EMA level and witnessed a sharp rally, surging over 6% in just 12 sessions. Along with this, it has surged above its short and long-term MAs. Sudeep Shah, Head, Technical & Derivatives Research (Equity), at SBI Securities, believes that 💰BSE, 💰PB Fintech, and 💰Paytm stocks are likely to continue their northward trek over the next few trading sessions.
08 Dec 2024 | 04:56 PM

M-cap of 6 of top 10 most valued firms jumps Rs 2 lakh crore

The market valuation of India's top 10 firms surged Rs 2,03,116.81 crore last week, led by Tata Consultancy Services and HDFC Bank, as the BSE benchmark jumped 1,906.33 points and NSE Nifty climbed 546.7 points. The biggest gainers included Reliance Industries, Infosys, State Bank of India, and ICICI Bank, while Bharti Airtel, LIC, ITC, and Hindustan Unilever were the laggards.
08 Dec 2024 | 12:02 PM

Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends!

For Nifty, the weekly price action formed a strong bull candle carrying higher high-low formation, indicating acceleration of up move. Stocks recommended to buy tomorrow by Dharmesh Shah-
📌Buy State Bank of India (SBI) in the range of 830-863 for the target of 950 with a stop loss of 787.
📌Buy Nalco in the range of 242-248 for the target of 266 with a stop loss of 235.
08 Dec 2024 | 06:34 PM

How to buy Glaxosmithkline Pharmaceuticals Ltd shares on nse?

To buy Glaxosmithkline Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Glaxosmithkline Pharmaceuticals Ltd share price today?

The Glaxosmithkline Pharmaceuticals Ltd shares price on nse is Rs.2346.4 today.

What is the market cap of Glaxosmithkline Pharmaceuticals Ltd shares on BSE ?

The company has a market capitalization of Rs.39749.43Cr

What is the PE & PB ratio of Glaxosmithkline Pharmaceuticals Ltd shares ?

PE is 49.94 and PB is 23.74

What is the 52 Week High and Low of Glaxosmithkline Pharmaceuticals Ltd shares?

Glaxosmithkline Pharmaceuticals Ltd stock price high: Rs.3087.95 Glaxosmithkline Pharmaceuticals Ltd stock price low: Rs.1664.75

What is the correct way to invest in Glaxosmith?

The correct way to invest in GlaxoSmithKline Pharmaceuticals is to buy the shares of the company through a reputed broker like Motilal Oswal. You can sign up with the broker online and open a dreamt and trading account first. Then, you can place an order to buy the company stock through the broker and invest in the company. 

How can I sell Glaxosmith Pharma shares?

To sell GlaxoSmithKline Pharmaceutical shares you must be signed up with a broker like Motilal Oswal. Shares must be held in a demat account to be sold. You also need to have a trading account linked to your demat account. Once you place a sell request with your broker, your shares are sold and the proceeds are credited to your bank account linked with your demat and trading accounts. 

What is the ROI of Glaxosmith Pharma shares?

The current year ROI (YTD 17 April 2023) of GlaxoSmithKline Pharmaceutical shares is -3.81%. 

Can I buy Glaxosmith Pharma shares now?

You can buy the shares of GlaxoSmithKline Pharmaceuticals now or at any time through a reputed broker like Motilal Oswal. All you require is a demat account linked with a trading account. These two accounts are connected to your bank account and you can easily place a buy order with your broker to buy the shares you want. 

What is the trending volume of Glaxosmith Pharma shares?

The trading volume of GlaxoSmithKline Pharmaceutical shares is 53,700 (17 April 2023).